NEW YORK (GenomeWeb News) — Agendia yesterday said that it has raised €25 million ($34 million) in a fourth financing round.
Bank-insurer ING becomes a shareholder, though Agendia would not disclose the amount it invested. However, Agendia called it a “powerful and substantial shareholder.”
Also participating in the round were current investors Van Herk Biotech, Gilde Healthcare Partners, and Gobal Life Science Ventures.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.